| Title | Zhodnocení a úprava medikacegeriatrem u seniorů s olyfarmakoterapií a multimorbiditou. Klinický doporučený postup výboru České gerontologické a geriatrické společnosti ČLS JEP |
| Publication Type | Journal Article |
| Year of Publication | 2024 |
| Authors | Topinkova E., Vaňková H., Šnajdrová Z., Matějková A. |
| Journal | Česká gerontologická<br/>a geriatrická společnost |
| Abstract | Evaluation and optimization of medication in seniors with polypharmacy and multimorbidity. Clinical guidelines of the Board of the Czech Society of Gerontology and Geriatrics, Czech Medical Association JEP Population aging, multimorbidity and polypharmacy increase the risk of medication-related harm. Improving patients’ safety, optimization, and rational prescribing aiming to decrease health care costs pose a new challenge for geriatric medicine. Comprehensive evaluation of medication and rational and safe prescribing in senior with high risk of adverse medication events, polypharmacy and chronic multimorbidity in the context of additional geriatric syndromes has a proven benefit for the safety of pharmacological treatment, health and functional status of seniors and decreased costs for health care. Presented Clinical guidelines for performing the evaluation and optimization of medication in seniors with polypharmacy and multimorbidity describe the content and methodology of the procedure. These clinical guidelines were developed and approved by the Board of the Czech Society of Gerontology and Geriatrics, CMA JEP based on international guidelines and currently are being recommended as a novel health procedure for the geriatric medicine specialty for the Ministry of Health Czech Republic approval. |
